Search results
Results from the WOW.Com Content Network
The primary goal in treatment of IIH is the prevention of visual loss and blindness, as well as symptom control. [9] IIH is treated mainly through the reduction of CSF pressure and IIH may resolve after initial treatment, may go into spontaneous remission (although it can still relapse at a later stage), or may continue chronically.
The study of visual changes and ICP in astronauts on long-duration flights is a relatively recent topic of interest to space medicine professionals. Although reported signs and symptoms have not appeared to be severe enough to cause blindness in the near term, long term consequences of chronically elevated intracranial pressure are unknown. [4]
This condition is similar to idiopathic intracranial hypertension, however the etiology in this instance is a drug. [16] The most frequent symptoms are headaches, pulsatile tinnitus, diplopia, and impairment of visual acuity. [15] [17] The only observable signs of the condition may be papilledema and bilateral sixth cranial nerve (abducens ...
Symptoms are frequently accompanied by visual disturbances such as gaze paresis, reduced vision, and dizziness. [1] Increased pressures within the skull can cause a compensatory elevation of blood pressure to maintain cerebral blood flow , which, when associated with irregular breathing and a decreased heart rate , is called the Cushing reflex ...
The treatment depends largely on the underlying cause. However, the root cause of papilledema is the increased intracranial pressure (ICP). This is a dangerous sign, indicative of a brain tumor , CNS inflammation or idiopathic intracranial hypertension (IIH) that may become manifest in the near future.
Which can result in a variety of neurological symptoms, such as pseudotumor cerebri, chronic fatigue syndrome, different types of headaches, visual disturbances, pulsatile tinnitus and various neurodegenerative diseases. [5] [6] [non-primary source needed] [7] [8] [non-primary source needed] [9] [better source needed] [1] [10] [excessive citations]
Acetazolamide is an inhibitor of carbonic anhydrase.It is used for glaucoma, epilepsy (rarely), idiopathic intracranial hypertension, and altitude sickness. For the reduction of intraocular pressure (IOP), acetazolamide inactivates carbonic anhydrase and interferes with the sodium pump, which decreases aqueous humor formation and thus lowers IOP.
Idiopathic orbital inflammatory (IOI) disease refers to a marginated mass-like enhancing soft tissue involving any area of the orbit.It is the most common painful orbital mass in the adult population, and is associated with proptosis, cranial nerve palsy (Tolosa–Hunt syndrome), uveitis, and retinal detachment.